Last reviewed · How we verify
NCT05725122
Stone Clearance in Patients With Upper Ureteric Stones Using Extracorporeal Shock Wave Lithotripsy Compared With Extracorporeal Shock Wave Lithotripsy Combined With Tamsulosin Therapy
NA trial testing Extracorporeal shock wave lithotripsy in Renal Stone in 82 participants. Completed in 31 December 2021.
31 December 2021
Quick facts
| Lead sponsor | Services Hospital, Lahore |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 82 |
| Start date | 1 February 2018 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Extracorporeal shock wave lithotripsy
- Extracorporeal Shock Wave Lithotripsy combined with Tamsulosin Therapy.
Conditions studied
- Renal Stone — all drugs for Renal Stone →
Sponsor
Services Hospital, Lahore
Who can join
Adults 18 to 70, any sex, with Renal Stone. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Extracorporeal shock wave lithotripsy (ESWL) is the least invasive and effective treatment for upper ureteric stones with a stone clearance rate of 60-90%. Tamsulosin is an alpha-blocker widely used in urological practice to relax smooth muscle of the prostate and bladder neck. Its role as part of medical expulsion therapy for the treatment of patients with kidney and ureteric stones has proved to be of considerable success. However, its role in clearing upper ureteric stones as an adjunct to ESWL is controversial. Therefore, this study will be conducted to evaluate its role in stone clearance along with extracorporeal shock wave lithotripsy in patients with upper ureteric stones
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05725122
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Extracorporeal shock wave lithotripsy
Trials testing the same drug.
- NCT07510178 — Retrograde Intrarenal Surgery Versus Extracorporeal Shockwave Lithotripsy · NA · not yet recruiting
- NCT07334236 — Energy Ramping Versus Fixed Dose ESWL · NA · not yet recruiting
- NCT06814834 — The Efficacy of Oral Dissolution Therapy (ODT), Extracorporeal Shock Wave Lithotripsy (ESWL), and Combined ESWL and ODT · NA · completed
- NCT03714477 — A Study to Investigate the Effect of Extracorporeal Shockwave Lithotripsy on Hypertension · NA · withdrawn
- NCT04819828 — Tamsulosin as Adjunctive Therapy After Extracorporeal Shock Wave Lithotripsy for Renal Stones · Phase 4 · completed
Other recruiting trials for Renal Stone
Currently open trials in the same condition.
- NCT07067996 — Erector Spinae Plane Block for Analgesia During ESWL · NA · recruiting
- NCT06786715 — Retrograde Intrarenal Surgery (RIRS) With Suction · NA · active not recruiting
- NCT06660914 — Robotic Flexible Ureteroscopy Versus Standard Flexible Ureteroscopy for Renal Stones · NA · recruiting
- NCT05894668 — Perioperative Parameter and Treatment Outcomes of ECIRS in Asia · recruiting
- NCT05697250 — High Versus Low Power Settings During Ureteroscopic Laser Lithotripsy · NA · recruiting
Other Services Hospital, Lahore trials
Trials by the same sponsor.
- NCT06239207 — Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia · Phase 2 · completed
- NCT07395388 — Intraoperative Methylene Blue Spray for the Identification and Preservation of Vital Structures in Thyroidectomy · NA · completed
- NCT05714423 — Outcomes in Lower Pole Kidney Stone Management Using Mini-PCNL Compared With Retrograde Intra Renal Surgery · NA · completed
- NCT07473388 — Clipless Versus Conventional Laparoscopic Cholecystectomy Using Harmonic Scalpel · NA · completed
- NCT07493343 — EUSOL vs. PDGF Dressing for Diabetic Foot Ulcers · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05725122 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Services Hospital, Lahore
- Last refreshed: 13 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05725122.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing